Myocardial infarction (MI) is a life-threatening condition that leads to loss of viable heart tissue. The best way to treat acute MI and limit the infarct size is to re-open the occluded coronary artery and restore the supply of oxygenated and nutrient-rich blood, but reperfusion can cause additional damage. Autophagy is an intracellular process that recycles damaged cytoplasmic components (molecules and organelles) by loading them into autophagosomes and degrading them in autolysosomes. Autophagy is increased in in vivo animal models of permanent ischemia and ischemia/reperfusion but by different molecular mechanisms. While autophagy is protective during permanent ischemia, it is detrimental during ischemia/reperfusion. Its modulation is being investigated as a potential target to reduce reperfusion injury. This review provides a synopsis of the current knowledge about autophagy, summarizes findings specifically in permanent ischemia and ischemia/reperfusion, and briefly discusses the potential implication of experimental findings.
Olfactory sensitivity to odorant molecules is a complex biological function influenced by both endogenous factors, such as genetic background and physiological state, and exogenous factors, such as environmental conditions. In animals, this vital ability is mediated by olfactory sensory neurons (OSNs), which are distributed across several specialized olfactory subsystems depending on the species. Using the phosphorylation of the ribosomal protein S6 (rpS6) in OSNs following sensory stimulation, we developed an ex vivo assay allowing the simultaneous conditioning and odorant stimulation of different mouse olfactory subsystems, including the main olfactory epithelium, the vomeronasal organ, and the Grueneberg ganglion. This approach enabled us to observe odorant-induced neuronal activity within the different olfactory subsystems and to demonstrate the impact of environmental conditioning, such as temperature variations, on olfactory sensitivity, specifically in the Grueneberg ganglion. We further applied our rpS6-based assay to the human olfactory system and demonstrated its feasibility. Our findings show that analyzing rpS6 signal intensity is a robust and highly reproducible indicator of neuronal activity across various olfactory systems, while avoiding stress and some experimental limitations associated with in vivo exposure. The potential extension of this assay to other conditioning paradigms and olfactory systems, as well as its application to other animal species, including human olfactory diagnostics, is also discussed.
Objectives: This study aims to define the surgical anatomy, technical feasibility, advantages, and limitations of the TPPA through detailed cadaveric dissection and a representative clinical case, evaluating its potential as a safe and effective alternative to traditional approaches to the mesiotemporal lobe. Methods: A cadaveric dissection was performed on one adult head injected with colored latex, using standard microsurgical instruments and high-definition video documentation. Each procedural step was recorded and illustrated with cadaveric photographs. Additionally, a clinical case of mesiotemporal cavernous hemangioma resected via TPPA is presented, including an operative video. Results: The dissection demonstrated a direct and safe trajectory to the amygdala and hippocampal head, with clear identification of key vascular and white matter landmarks. In the clinical case, the lesion was completely resected with no postoperative neurological deficits. Conclusions: The TPPA represents a novel microsurgical corridor to the mesiotemporal region, minimizing cortical disruption, Sylvian fissure dissection, and manipulation of middle cerebral artery branches. Although its exposure is limited posteriorly, the TPPA could offer an optimal balance between functional preservation and surgical accessibility, constituting a valuable addition to the modern microsurgical armamentarium.
BACKGROUND AND OBJECTIVES: The occipital artery–vertebral artery (OA–VA) bypass of the V3 segment has been described as a possible feasible revascularization strategy through the anterolateral approach. However, the impact of C1 transverse process removal on surgical corridor expansion, VA mobility, and microsurgical ergonomics has not been evaluated. In this cadaveric study, we assessed the anatomic and ergonomic effect of C1 transversectomy for OA–V3 bypass. METHODS: Five injected cadaveric specimens (10 sides) were subjected to paired analysis comparing standard anterolateral exposure (baseline) vs the same approach with C1 transversectomy and VA skeletonization. Quantitative end points included surgical working area, exposed VA length, working depth, and instrument divergence angle. Paired statistical analysis was calculated. RESULTS: C1 transversectomy resulted in a significant improvement in all major parameters of surgical exposure. The working area increased by 130% (from 226.1 to 519.1 mm 2 , P < .001), whereas the exposed VA length increased by 84% (from 12.7 to 23.4 mm, P = .002). VA mobility demonstrated the greatest relative gain, increasing by 207% (from 1.5 to 4.6 mm, P < .001). The instrument divergence angle also significantly improved, increasing by 109% (from 18.2° to 38.1°, P < .001). No statistically significant changes were observed in working depth. CONCLUSION: C1 transversectomy markedly enhances exposure, mobility, and operative ergonomics within the anterolateral OA–V3 corridor. These findings provide quantitative anatomic validation of a technical refinement that may improve reproducibility and safety of OA–VA bypass in selected clinical scenarios.